Robust neutralising activity and activation of neutrophil cytotoxic responses mediated by antibodies targeting the HTLV-1 envelope glycoprotein
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Robust neutralising activity and activation of neutrophil cytotoxic responses mediated by antibodies targeting the HTLV-1 envelope glycoprotein ; volume:8 ; number:1 ; day:6 ; month:6 ; year:2011 ; pages:1 ; date:12.2011
Retrovirology ; 8, Heft 1 (6.6.2011), 1, 12.2011
- Urheber
-
Kuo, Chien-Wen
- Beteiligte Personen und Organisationen
-
Tulloch, Lindsay
Brighty, David W.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-8-S1-A170
- URN
-
urn:nbn:de:1111-2016080718875
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuo, Chien-Wen
- Tulloch, Lindsay
- Brighty, David W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
Membrane topology analysis of HIV-1 envelope glycoprotein gp41
Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein
Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
Membrane topology analysis of HIV-1 envelope glycoprotein gp41
Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein
Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
Membrane topology analysis of HIV-1 envelope glycoprotein gp41
Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein
Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection